Title:
SERUM LIPID MARKER RELATED TO FUNDUS HARD EXUDATES IN DIABETIC RETINOPATHY, AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/072261
Kind Code:
A1
Abstract:
Provided are a serum lipid marker related to fundus hard exudates in diabetic retinopathy, and an application thereof. Specifically, provided is a biomarker set related to fundus hard exudates in diabetic retinopathy. The set comprises biomarkers in the following group: A1: Cer 42:0; 4O, DG36:0 and ADGGA 52:2. The biomarker can evaluate the risk or degree of fundus hard exudates in human diabetic retinopathy with high specificity and high accuracy.
Inventors:
SHEN YINCHEN (CN)
FANG JUNWEI (CN)
LIU KUN (CN)
FANG JUNWEI (CN)
LIU KUN (CN)
Application Number:
PCT/CN2022/128332
Publication Date:
May 04, 2023
Filing Date:
October 28, 2022
Export Citation:
Assignee:
SHANGHAI FIRST PEOPLES HOSPITAL (CN)
International Classes:
G01N30/02; G01N30/06; G01N30/72; G01N30/88
Domestic Patent References:
| WO2021150011A1 | 2021-07-29 |
Foreign References:
| CN107133470A | 2017-09-05 | |||
| CN112198233A | 2021-01-08 | |||
| CN112505228A | 2021-03-16 | |||
| US20100179307A1 | 2010-07-15 | |||
| CN113544513A | 2021-10-22 | |||
| CN112697889A | 2021-04-23 | |||
| CN112877420A | 2021-06-01 |
Other References:
OLA MOHAMMAD SHAMSUL, NAWAZ MOHD IMTIAZ, SIDDIQUEI M. MAIRAJ, AL-AMRO SALEH, ABU EL-ASRAR AHMED M.: "Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy", JOURNAL OF DIABETES AND ITS COMPLICATIONS, ELSEVIER SCIENCE, NEW YORK, NY, US, vol. 26, no. 1, 1 January 2012 (2012-01-01), US , pages 56 - 64, XP093061174, ISSN: 1056-8727, DOI: 10.1016/j.jdiacomp.2011.11.004
Attorney, Agent or Firm:
XU&PARTNERS, LLC. (CN)
Download PDF: